Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma (Q69227825)
Jump to navigation
Jump to search
scientific article published on 01 September 1987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma |
scientific article published on 01 September 1987 |
Statements
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma (English)
N K Cheung
H Lazarus
F D Miraldi
C R Abramowsky
S Kallick
U M Saarinen
T Spitzer
S E Strandjord
P F Coccia
N A Berger
1 September 1987